Privacy Policy
Signals Blog

Contributors

Categories

BRM2017: State of the regenerative medicine industry

Although new to the field of science communication, Nathan Holwell has been involved in a variety of research during his undergraduate career and now in his graduate career. He has done research in drug delivery, gene delivery, biomaterials and diagnostic devices. His...

Right Turn: Primers on cell therapy regulation

Understanding cell therapy regulation is an essential component of the bench to bedside pipeline. Without approval from a country’s regulator (Health Canada, FDA, EMA, PMDA, etc.), a product cannot be sold to consumers and the millions invested in research and...

Five regenerative medicine workshops to attend this summer

Amin Adibi is a biomedical engineer and a health data analyst at the University of British Columbia. His areas of interest include cell manufacturing and bioprocess optimization, clinical translation of cellular therapies, health outcomes and cost-effectiveness...

Right Turn: The robots aren’t coming, they’re here

via GIPHY Artificial Intelligence (AI) already permeates our culture and that’s only going to increase with time and advances to the technology. Some think this is good news, progress and inevitable while others, like Stephen Hawking for example, fear where AI could...